Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement
- PMID: 20065856
- DOI: 10.1097/RLI.0b013e3181cc2929
Handling a high relaxivity contrast material for dynamic breast MR imaging using higher thresholds for the initial enhancement
Abstract
Objectives: To increase specificity of gadobenate dimeglumine-enhanced breast magnetic resonance (MR) imaging without losing sensitivity.
Materials and methods: IRB approval was obtained for this retrospective study and informed consent was waived. Sixty-eight patients with 73 breast lesions underwent dynamic breast 1.5-T MR imaging with 0.1 mmol/kg of gadobenate dimeglumine and 103 or 111-second temporal resolution. A score system based on shape (round/oval/lobular = 0, linear/dendritic/stellate = 1), margins (defined = 0, undefined = 1), pattern (homogeneous = 0, inhomogeneous = 1, rim = 2), kinetics (continuous = 0, plateau = 1, washout = 2), and initial enhancement was used. Initial enhancement was evaluated with standard (<50% = 0, 50%-100% = 1, >100% = 2) or adjusted (<180% = 0, 180%-240% = 1, >240% = 2) thresholds. Scores 0-2, 3, 4 or 5, and from 6 to 8 were considered as equivalent to Breast Imaging Reporting and Data System 2, 3, 4, and 5, respectively. Pathologic examination (core-, vacuum-assisted, or surgical biopsy) served as a reference standard. Nonparametric tests were used.
Results: At histopathology, 52 lesions were malignant, 21 were benign. The initial enhancement for benign lesions was 141% +/- 65% (mean +/- SD), whereas for malignant lesions it was 210% +/- 80% (P = 0.001). The median multifactorial score for benign lesions was 4 using the standard thresholds and 3 using the adjusted thresholds (P < 0.001) whereas for malignant lesions it was 7 and 6, respectively (P < 0.001). Specificity increased from 38% with standard thresholds to 71% with adjusted thresholds (gain of 33%; P = 0.016); positive predictive value 80% and 90%, negative predictive value 100% and 100%, and accuracy 82% and 92%, respectively. Sensitivity was 100% for both thresholds.
Conclusions: Specificity of gadobenate dimeglumine-enhanced breast MR imaging can be increased without limiting its high sensitivity.
Similar articles
-
Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.Invest Radiol. 2008 Apr;43(4):236-42. doi: 10.1097/RLI.0b013e318160678d. Invest Radiol. 2008. PMID: 18340247
-
Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.Radiology. 2007 Jun;243(3):670-80. doi: 10.1148/radiol.2433060838. Epub 2007 Apr 19. Radiology. 2007. PMID: 17446524
-
Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.AJR Am J Roentgenol. 2008 Nov;191(5):1339-46. doi: 10.2214/AJR.07.3533. AJR Am J Roentgenol. 2008. PMID: 18941066 Clinical Trial.
-
Breast MRI using a high-relaxivity contrast agent: an overview.AJR Am J Roentgenol. 2011 Apr;196(4):942-55. doi: 10.2214/AJR.10.4974. AJR Am J Roentgenol. 2011. PMID: 21427349 Review.
-
Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents.Radiographics. 2011 Oct;31(6):1547-68. doi: 10.1148/rg.316115528. Radiographics. 2011. PMID: 21997981 Review.
Cited by
-
Use of contrast agents in oncological imaging: magnetic resonance imaging.Cancer Imaging. 2013 Sep 23;13(3):350-9. doi: 10.1102/1470-7330.2013.9018. Cancer Imaging. 2013. PMID: 24060901 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical